poisar

Stock

Tonix Pharmaceuticals Holding Corp. TNXP

$13.54-0.77%

Overview

TNXP market data

Price History

TNXP price chart · 1M
O
13.69
H
14.04
L
13.46
C
13.54
Vol
34,300.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$13.69
Previous Close
$13.64
Day High
$14.04
Day Low
$13.46
52 Week High
$15.81
52 Week Low
$9.44
7 Day Return
+9.37%
30 Day Return
+36.30%
90 Day Return
+9.51%
1 Year Return
+9.15%
Daily Notional Volume
$464.3K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$14.57
Diluted earnings per share over the trailing twelve months.
Beta
1.77
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-839.5%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$9.40 – $37.56
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $214.4M · P/B 0.81 · P/S 12.21.

Company News

10 captured
8-K filing — Tonix Pharmaceuticals Holding Corp. (TNXP)SEC EDGAR · Aug 18, 2026, 8:00 PM
Tonix Pharmaceuticals Q2 EPS $(2.44) Beats $(2.64) Estimate, Sales $13.544M Beat $7.723M EstimateBenzinga · Aug 10, 2026, 11:01 AM
Tonix Pharma Receives Official Minutes From Type C Meeting With FDA To Discuss Plans For Adaptive Phase 2 Field Study Of TNX-4800 To Prevent Lyme Disease In Adults In USBenzinga · Aug 3, 2026, 11:11 AM
Tonix Pharma Announces Publication Of Monkeypox Study In Journal Of Virology, Peer-Reviewed Publication Of ASMBenzinga · Jul 15, 2026, 1:07 PM
Tonix Secures Medicare Coverage For Fibromyalgia Drug TONMYA, Expands TONMYA Coverage To 145M Lives By 2027Benzinga · Jul 13, 2026, 11:07 AM
Tonix Pharmaceuticals Enrolled First Patient In Phase 2 HORIZON Study Of TNX-102 SL For MDD; Primary Endpoint Is Change In MADRS Total Score At Week 6Benzinga · Jun 29, 2026, 11:15 AM
This Keurig Dr Pepper Analyst Turns Bullish; Here Are Top 4 Upgrades For ThursdayBenzinga · Jun 25, 2026, 4:25 PM
This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For ThursdayBenzinga · Jun 25, 2026, 2:20 PM
This Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For ThursdayBenzinga · Jun 25, 2026, 12:50 PM
Tonix Shares Jump After Landing Second Commercial Payer Agreement For TONMYABenzinga · Jun 8, 2026, 12:45 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock